464 related articles for article (PubMed ID: 2860147)
1. Regional coronary vasoconstriction after combined beta-adrenergic and calcium channel blockade in patients with coronary artery disease.
Kern MJ; Petru MA; Ferry DR; Eilen SD; Barr WK; Porter CB; O'Rourke RA
J Am Coll Cardiol; 1985 Jun; 5(6):1438-50. PubMed ID: 2860147
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of coronary vasoconstriction by beta-adrenergic blockade in patients with coronary artery disease.
Kern MJ; Ganz P; Horowitz JD; Gaspar J; Barry WH; Lorell BH; Grossman W; Mudge GH
Circulation; 1983 Jun; 67(6):1178-85. PubMed ID: 6133636
[TBL] [Abstract][Full Text] [Related]
3. Prevention of nifedipine of abnormal coronary vasoconstriction in patients with coronary artery disease.
Gunther S; Green L; Muller JE; Mudge GH; Grossman W
Circulation; 1981 Apr; 63(4):849-55. PubMed ID: 7471341
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of cocaine-induced coronary vasoconstriction by beta-adrenergic blockade.
Lange RA; Cigarroa RG; Flores ED; McBride W; Kim AS; Wells PJ; Bedotto JB; Danziger RS; Hillis LD
Ann Intern Med; 1990 Jun; 112(12):897-903. PubMed ID: 1971166
[TBL] [Abstract][Full Text] [Related]
5. Coronary hemodynamic and metabolic effects of nifedipine in patients with coronary artery disease treated with beta-blocking drugs.
Schanzenbächer P; Göttfert G; Liebau G; Kochsiek K
Am J Cardiol; 1985 Jan; 55(1):33-6. PubMed ID: 3966396
[TBL] [Abstract][Full Text] [Related]
6. Effects of beta-adrenergic blockade on nitroglycerin-induced augmentation of regional coronary blood flow in patients.
Miller JT; Kern MJ; Henry RL
Cathet Cardiovasc Diagn; 1988; 15(1):15-22. PubMed ID: 2900687
[TBL] [Abstract][Full Text] [Related]
7. Therapy of coronary vasoconstriction in patients with coronary artery disease.
Gunther S; Muller JE; Mudge GH; Grossman W
Am J Cardiol; 1981 Jan; 47(1):157-62. PubMed ID: 6779618
[TBL] [Abstract][Full Text] [Related]
8. Differential hemodynamic effects of beta-adrenoceptor blockers, Ca antagonists and combined alpha-beta-receptor blockade in ischemic heart disease.
Koch G
Acta Med Scand; 1986; 219(1):17-22. PubMed ID: 2869648
[TBL] [Abstract][Full Text] [Related]
9. Influence of carvedilol and propranolol on coronary blood flow.
Sievert H; Frey G; Schräder R; Schmidt T; van der Does R; Kaltenbach M; Kober G
Eur J Clin Pharmacol; 1990; 38 Suppl 2():S122-4. PubMed ID: 1974502
[TBL] [Abstract][Full Text] [Related]
10. Effect of nifedipine on coronary hemodynamics in patients with left anterior descending coronary occlusion.
Feldman RL; Hill JA; Conti CR; Pepine CJ
J Am Coll Cardiol; 1985 Feb; 5(2 Pt 1):318-25. PubMed ID: 3968317
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effect of verapamil and propranolol on response of coronary vasomotion to cold pressor test in symptomatic patients with hypertrophic cardiomyopathy.
Dimitrow PP; Krzanowski M; Nizankowski R; Szczeklik A; Dubiel JS
Cardiovasc Drugs Ther; 2000 Dec; 14(6):643-50. PubMed ID: 11300365
[TBL] [Abstract][Full Text] [Related]
12. Myocardial properties of the new dihydropyridine calcium antagonist isradipine compared to nifedipine with or without additional beta blockade in coronary artery disease.
Mauser M; Voelker W; Ickrath O; Karsch KR
Am J Cardiol; 1989 Jan; 63(1):40-4. PubMed ID: 2562817
[TBL] [Abstract][Full Text] [Related]
13. The effects of nisoldipine (Bay K 5552) on cardiovascular performance and regional blood flow in pentobarbital-anaesthetized pigs with or without beta-adrenoceptor blockade.
Duncker DJ; Hartog JM; Hugenholtz PG; Saxena PR; Verdouw PD
Br J Pharmacol; 1986 May; 88(1):9-18. PubMed ID: 2871886
[TBL] [Abstract][Full Text] [Related]
14. Effects of nifedipine on coronary hemodynamic findings during exercise in patients with stable exertional angina.
Specchia G; de Servi S; Falcone C; Angoli L; Gavazzi A; Bramucci E; Mussini A; Ferrario M; Salerno J; Montemartini C
Circulation; 1983 Nov; 68(5):1035-43. PubMed ID: 6616787
[TBL] [Abstract][Full Text] [Related]
15. Cigarette smoking-induced coronary vasoconstriction in atherosclerotic coronary artery disease and prevention by calcium antagonists and nitroglycerin.
Winniford MD; Jansen DE; Reynolds GA; Apprill P; Black WH; Hillis LD
Am J Cardiol; 1987 Feb; 59(4):203-7. PubMed ID: 3101478
[TBL] [Abstract][Full Text] [Related]
16. Inappropriate coronary vasoconstriction in patients with coronary artery disease: a role for nifedipine?
Gunther S; Green L; Muller JE; Mudge GH; Grossman W
Am J Cardiol; 1979 Oct; 44(5):793-7. PubMed ID: 386763
[TBL] [Abstract][Full Text] [Related]
17. Effect of tiapamil and nifedepine during critical coronary stenosis and in the presence of adrenergic beta-receptor blockade in anesthetized dogs.
Saini RK; Fulmor IE; Antonaccio MJ
J Cardiovasc Pharmacol; 1982; 4(5):770-6. PubMed ID: 6182408
[TBL] [Abstract][Full Text] [Related]
18. Effects of a calcium-channel antagonist on large and small coronary arteries in conscious dogs.
Vatner SF; Hintze TH
Circulation; 1982 Sep; 66(3):579-88. PubMed ID: 6124327
[TBL] [Abstract][Full Text] [Related]
19. Is there coronary vasoconstriction after intracoronary beta-adrenergic blockade in patients with coronary artery disease.
Gaglione A; Hess OM; Corin WJ; Ritter M; Grimm J; Krayenbuehl HP
J Am Coll Cardiol; 1987 Aug; 10(2):299-310. PubMed ID: 3110237
[TBL] [Abstract][Full Text] [Related]
20. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
